Evidence map›Paper›PMID 41251137›Full record

ArticleJournal of medical virology2025

One-Year Quality of Life Among Survivors of Hospitalization for Omicron Infection in Brazil: A Multicentre Prospective Cohort Study.

Geraldine Trott, Marciane Maria Rover, Fernando Luis Scolari, Mariana Motta Dias da Silva, Denise de Souza, Rosa da Rosa Minho Dos Santos, Raíne Fogliati De Carli, Emelyn de Souza Roldão, Gabriela Soares Rech, Duane Mocellin and 46 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Geraldine TrottProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Marciane Maria RoverProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Fernando Luis ScolariProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Mariana Motta Dias da SilvaResearch Institute, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Denise de SouzaProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Rosa da Rosa Minho Dos SantosProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Raíne Fogliati De CarliProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Emelyn de Souza RoldãoProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Gabriela Soares RechProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Duane MocellinProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Jennifer Menna Barreto de SouzaProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Aline Paula MiozzoProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Carolina Rothmann ItaquiProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Gabrielle Nunes da SilvaProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Sergio Renato da Rosa DeckerProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.ORCID 0000-0001-6989-3079
Erica Neves LeiteProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Carlos Delmar do Amaral FerreiraHospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Lucas Gobetti da LuzHospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Gabriel Beilfuss RiethHospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Lucas TramujasHCor Research Institute, São Paulo, São Paulo, Brazil.
Fernando Azevedo MedradoHCor Research Institute, São Paulo, São Paulo, Brazil.
Bruna Fornazieri PiottoHCor Research Institute, São Paulo, São Paulo, Brazil.
Gizelle Fernanda Oliveira SilvaHospital Metropolitano Dr. Célio de Castro, Belo Horizonte, Minas Gerais, Brazil.
Josafá Ferreira ChavesHospital Metropolitano Dr. Célio de Castro, Belo Horizonte, Minas Gerais, Brazil.
Saionara Cristina FranciscoHospital Metropolitano Dr. Célio de Castro, Belo Horizonte, Minas Gerais, Brazil.
Precil Diego Miranda de Menezes NevesInternal Medicine Department, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Victor Augusto Hamamoto SatoInternal Medicine Department, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Viviane Cordeiro VeigaHospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Kaique Lima MartinsHospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Cláudio Dornas de OliveiraHospital Santa Casa BH, Belo Horizonte, Minas Gerais, Brazil.
Sabrina Gomes Dos SantosHospital Santa Casa BH, Belo Horizonte, Minas Gerais, Brazil.
Juliana Cardozo FernandesHospital Ernesto Dornelles, Porto Alegre, Rio Grande do Sul, Brazil.
Thiago Costa LisboaHospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Vivian Menezes IrineuHospital Doutor Leo Orsi Bernardes, Itapetininga, São Paulo, Brazil.
Mauricio Antonio PompilioHospital do Coração de Mato Grosso do Sul, Campo Grande, Brazil.
Adriana de Oliveira FrançaHospital do Coração de Mato Grosso do Sul, Campo Grande, Brazil.
Aline Coletto JaccottetRS Heart Institute, Fundação Universitária de Cardiologia, Porto Alegre, Rio Grande do Sul, Brazil.
Juliana Carvalho SchlederCenter for Studies, Research, and Human Development, Hospitais da Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brazil.
Vinicius Ortigosa NogueiraTropical Medicine Research Center (CEPEM), Porto Velho, Rondônia, Brazil.
Vandack NobreHospital de Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Daniel Souto SilveiraHospitalize Clinical and Population Research Center, Guaíba, Rio Grande do Sul, Brazil.
Cézar Eumann MesasHospital Universitário de Londrina, Londrina, Paraná, Brazil.
Diego MiltersteinerHospital Universitário de Canoas, Canoas, Rio Grande do Sul, Brazil.
Emanuelle Toledo OrtizHospital Universitário de Canoas, Canoas, Rio Grande do Sul, Brazil.
Fernando Gioppo BlauthHospital Beneficência Portuguesa de Ribeirão Preto, São Paulo, Brazil.
Luciane Maria FacchiAssociação Hospitalar Vila Nova, Porto Alegre, Rio Grande do Sul, Brazil.
Milena Soriano MarcolinoDepartment of Clinical Medicine, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ana Carolina Peçanha AntonioHospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Paulo R SchvartzmanCardiology Department, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Bruna Brandão BarretoIntensive Care Unit, Hospital da Mulher - Maria Luzia Costa dos Santos, Salvador, Bahia, Brazil.
Caroline Cabral RobinsonProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Maicon FalavignaResearch Unit, Inova Medical, Porto Alegre, Rio Grande do Sul, Brazil.
Carisi Anne PolanczykCardiology Department, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Luiz Antonio NasiHospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Regis Goulart RosaProjects Office, Hospital Moinhos de Vento, Rio Grande do Sul, Brazil.
Post‐Covid Brasil 1 Group Autorship

Funding

This study was funded by Programa de Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS), a Brazilian Ministry of Health program that supports public interest projects conducted by selected health institutions of excellence.
6 · The paper itself

Abstract

The lingering effects of COVID-19 may impair survivors' long-term health-related quality of life (HRQoL). However, multicentre studies focusing on the Omicron variant, particularly in middle- and low-income settings, are scarce. We conducted a prospective cohort study across 24 Brazilian hospitals between December 2021 and March 2024, when Omicron was the predominant variant. Adult COVID-19 survivors were followed for 12 months via telephone interviews. The primary outcome was HRQoL at 12 months, assessed using the EuroQol five-dimension three-level questionnaire (EQ-5D-3L; range -0.17 to 1.0). All-cause mortality was a secondary outcome. Among 649 participants (47.9% women; median age 71 years), the median EQ-5D-3L utility score at 12 months was 0.69 (IQR 0.41-0.80), and survival was 86.6%. Factors associated with lower HRQoL included female sex, age ≥ 60 years, Charlson comorbidity index ≥ 1, and need for respiratory support. Mortality was associated with age ≥ 60 years (HR 2.81), CCI ≥ 2 (HR 2.17), need for low-flow oxygen therapy (HR 2.03), and BMI ≥ 25 kg/m² (HR 0.58). One year after hospitalization, Omicron survivors in Brazil showed impaired HRQoL and high mortality. Older age, comorbidities, and need for oxygen therapy were linked to worse outcomes. Long-term support strategies are needed for these vulnerable populations.

Indexed as

COVID-19Quality of LifeSurvivorsAdultAgedAged, 80 and overBrazilFemaleHospitalizationHumansMaleMiddle AgedProspective StudiesSARS-CoV-2Surveys and QuestionnairesBrazilCOVID‐19Omicron variantpost‐acute COVID‐19 syndromequality of lifeSARS‐CoV‐2

Identifiers

PMID41251137
PMCPMC12624822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.